Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.
about
Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulationFactor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementiaBrain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsMethamphetamine abuse, HIV infection, and neurotoxicity.CCL3 genotype and current depression increase risk of HIV-associated dementiaM-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatumChronic exposure to the chemokine CCL3 enhances neuronal network activity in rat hippocampal cultures.beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration.Microglia in human immunodeficiency virus-associated neurodegeneration.Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.Pharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury.Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementiaCCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotectionPlasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.Human immunodeficiency virus-associated dementia: a link between accumulation of viral proteins and neuronal degeneration.Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.HIV-1 infection and AIDS: consequences for the central nervous system.When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?RANTES levels in peripheral blood, CSF and contused brain tissue as a marker for outcome in traumatic brain injury (TBI) patientsBiomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approachesChronic CXCL10 alters the level of activated ERK1/2 and transcriptional factors CREB and NF-kappaB in hippocampal neuronal cell cultureBiomarkers of HIV related central nervous system disease.CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.HIV-1 Nef induces CCL5 production in astrocytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB, CEBP and AP-1 transcription factors.European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection.Cognitive impairment and major depressive disorder in HIV infection and cerebrospinal fluid biomarkers.HIV/neuroAIDS biomarkers.Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)--2',3'-dideoxycytidine (ddC): relevance to HIV-dementiaHIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways.SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study.
P2860
Q28205775-62FB064B-603B-443D-8F5C-CBAB17C8F7D4Q33525781-F8F69850-EB74-49BD-99BD-6A5B2D52CFFEQ33614467-531B8E32-11D7-45F4-B4EF-2EF7A3BC572EQ33799373-9D319DF1-9F61-4BA2-AF17-781C0F19F557Q34072394-DBF2CA32-B2DA-4FB0-B57C-B1C62455690DQ34075705-5C5B0F8E-CFBC-4FFA-A328-123D73DECB4FQ34348557-9FA3A34F-8610-45D6-8C85-426C77F78F0BQ34356438-F95915D3-3F27-48E9-9ED1-EC4A039C304DQ34963796-7EA1BF93-DB2F-4C63-81C1-B486F824A59AQ35125996-E3095E27-C6FE-4AAB-91DD-D0A51825B717Q35137844-512B1FCD-A4C5-488D-A8C0-3D7FDD01E2D5Q35197030-AB39E740-6830-43E3-9BFC-0AB02C2B6B86Q35207533-36CA081A-FF65-4097-97C3-73AE6F6D4459Q35522971-AC321E1A-AB41-433C-91C6-774C8780608FQ35582240-F38471B9-FF3A-44C8-BBF7-8D72906840C2Q35702700-AE6E38F9-62C7-4A86-9EED-22AE10BBC313Q36060674-BCBD07C7-5654-42D3-AFD6-D260900F9DD0Q36098879-0C649B2E-F174-4A88-A5E8-F52D6634460DQ36188164-82C2AE6E-8760-45F1-B731-EFCF0C67A40BQ36322531-CE23CFF1-288F-4B4D-A579-505B4D3F0805Q36530897-C0F26752-66D9-44F1-B28F-572B04C5F08CQ36676858-4432C683-9AE6-4C82-B221-FED6A24C991AQ37073672-1E8C9F84-C565-4267-BF35-2BAD09BD4F78Q37600700-98060F52-8D4C-408A-89A3-D4B432E802D2Q37657314-49417FD1-65FC-4E9D-BF41-08F2D43FAE16Q37701959-569A17EC-CC68-43D6-BB54-BB73B4F51365Q38154123-7580D39D-D670-463D-BBF8-290FE45B72AAQ38809646-45958A1D-1DA7-4F13-8E44-5117C8630A26Q39603836-A985AE8A-BAD0-4F4A-87FB-79B0D206E606Q41862645-5E0224A8-0B46-448B-9DAD-F1BC8F0936FBQ42097093-FBB44C1D-ABFD-4DC3-82AA-9E5097DE595FQ42443945-6DEC84C2-E54C-4A61-8806-A602AA986462
P2860
Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Cerebrospinal fluid beta chemo ...... immunodeficiency virus type 1.
@en
type
label
Cerebrospinal fluid beta chemo ...... immunodeficiency virus type 1.
@en
prefLabel
Cerebrospinal fluid beta chemo ...... immunodeficiency virus type 1.
@en
P2093
P356
P1476
Cerebrospinal fluid beta chemo ...... immunodeficiency virus type 1.
@en
P2093
Letendre SL
McCutchan JA
P304
P356
10.1086/314866
P407
P577
1999-08-01T00:00:00Z